Company: NCNO
Filing Date: 2025-08-26
Form Type: 10-Q
Source: 0001902733-25-000106
Chunk: 77

Company: nCino, Inc.
Filing Date: 2025-08-26
Form: 10-Q
Item: Part I, Item 1
Chunk 77
---
 components of basic and diluted loss per share for periods presented are as follows (in thousands, except share and per share data):Three Months Ended July 31,Six Months Ended July 31,2024202520242025Basic and diluted loss per share:NumeratorNet loss attributable to nCino, Inc.$(11,040)$(15,257)$(14,016)$(9,695)DenominatorWeighted-average common shares outstanding115,180,130 115,256,497 114,694,001 114,657,339 Basic and diluted loss per share attributable to nCino, Inc.$(0.10)$(0.13)$(0.12)$(0.08)The following potential outstanding common stock were excluded from the diluted loss per share computation because the effect would have been anti-dilutive:Six Months Ended July 31,20242025Stock options issued and outstanding998,618 562,629 Nonvested RSUs issued and outstanding6,362,337 6,951,460 Shares issuable pursuant to the ESPP81,048 89,919 

Note 14. Segment Information

The Company's chief operating decision maker ("CODM") is the Company's Chief Executive Officer, who reviews financial information on a consolidated basis. The Company brings together people and data to enable financial institutions to enhance strategic decision-making, risk management, and customer satisfaction through the selection of intelligent solutions provided by the nCino Platform as a SaaS company. As such, the Company has one operating and reportable segment. The CODM uses consolidated net loss in deciding how to make operating decisions, allocate resources, and assess performance. 

28

Table of ContentsnCino, Inc.NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(In thousands, except share and per share amounts and unless otherwise indicated)

The following table presents selected financial information that is provided to our CODM:Three Months Ended July 31,Six Months Ended July 31,2024202520242025Revenues$132,403 $148,815 $260,490 $292,952 Less:Adjusted cost of revenues(1)45,671 50,129 89,310 99,249 Adjusted sales and marketing expense(1)24,667 28,093 46,274 53,769 Adjusted research and development expense(1)28,985 26,590